Literature DB >> 31392073

New insights into autophagy in hepatocellular carcinoma: mechanisms and therapeutic strategies.

Shuo Yang1, Liang Yang1, Xinyu Li1, Bowen Li1, Yan Li1, Xiaodong Zhang1, Yingbo Ma1, Xueqiang Peng1, Hongyuan Jin1, Hangyu Li1.   

Abstract

Autophagy is a mechanism by which cellular substances are transported to lysosomes for degradation, allowing the basic transformation of cellular components, and providing energy and macromolecular precursors. In cancer, the contradictory role of autophagy in tumor suppression and promotion has been widely acknowledged. Activation and suppression of autophagy have been proposed as cancer therapies, resulting in targeted treatment of cancer by autophagy being considered ambiguous. The dynamic effect of autophagy can also be applied to hepatocellular carcinoma (HCC), a malignant tumor with high incidence and a low survival rate. In this review, we introduce characteristics of different types of autophagy and summarize which genes, non-coding RNAs, and related signaling pathways are involved in autophagy and the regulation of the formation and progress of HCC. More importantly, we discuss the role of autophagy in the treatment of HCC, such as in traditional chemotherapy, molecular targeted drugs, and natural products.

Entities:  

Keywords:  Autophagy; hepatocellular carcinoma; noncoding RNAs; signaling pathways; therapy

Year:  2019        PMID: 31392073      PMCID: PMC6682711     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  186 in total

1.  LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.

Authors:  Y Kabeya; N Mizushima; T Ueno; A Yamamoto; T Kirisako; T Noda; E Kominami; Y Ohsumi; T Yoshimori
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

Review 2.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

3.  A unified nomenclature for yeast autophagy-related genes.

Authors:  Daniel J Klionsky; James M Cregg; William A Dunn; Scott D Emr; Yasuyoshi Sakai; Ignacio V Sandoval; Andrei Sibirny; Suresh Subramani; Michael Thumm; Marten Veenhuis; Yoshinori Ohsumi
Journal:  Dev Cell       Date:  2003-10       Impact factor: 12.270

4.  u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma.

Authors:  D Tavian; G De Petro; A Benetti; N Portolani; S M Giulini; S Barlati
Journal:  Int J Cancer       Date:  2000-09-01       Impact factor: 7.396

5.  Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival.

Authors:  Satoshi Inagawa; Masayuki Itabashi; Shinya Adachi; Toru Kawamoto; Masao Hori; Jiro Shimazaki; Fuyo Yoshimi; Katashi Fukao
Journal:  Clin Cancer Res       Date:  2002-02       Impact factor: 12.531

6.  Amino acids interfere with the ERK1/2-dependent control of macroautophagy by controlling the activation of Raf-1 in human colon cancer HT-29 cells.

Authors:  Sophie Pattingre; Chantal Bauvy; Patrice Codogno
Journal:  J Biol Chem       Date:  2003-02-27       Impact factor: 5.157

7.  Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor.

Authors:  Zhenyu Yue; Shengkan Jin; Chingwen Yang; Arnold J Levine; Nathaniel Heintz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

8.  Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.

Authors:  Brinda Ravikumar; Coralie Vacher; Zdenek Berger; Janet E Davies; Shouqing Luo; Lourdes G Oroz; Francesco Scaravilli; Douglas F Easton; Rainer Duden; Cahir J O'Kane; David C Rubinsztein
Journal:  Nat Genet       Date:  2004-05-16       Impact factor: 38.330

Review 9.  JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.

Authors:  L S Steelman; S C Pohnert; J G Shelton; R A Franklin; F E Bertrand; J A McCubrey
Journal:  Leukemia       Date:  2004-02       Impact factor: 11.528

10.  Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene.

Authors:  Xueping Qu; Jie Yu; Govind Bhagat; Norihiko Furuya; Hanina Hibshoosh; Andrea Troxel; Jeffrey Rosen; Eeva-Liisa Eskelinen; Noboru Mizushima; Yoshinori Ohsumi; Giorgio Cattoretti; Beth Levine
Journal:  J Clin Invest       Date:  2003-11-24       Impact factor: 14.808

View more
  19 in total

1.  Disulfiram blocked cell entry of SARS-CoV-2 via inhibiting the interaction of spike protein and ACE2.

Authors:  Hsiao-Fan Chen; Po-Ren Hsueh; Yen-Yi Liu; Yeh Chen; Sui-Yuan Chang; Wei-Jan Wang; Chen-Shiou Wu; Ya-Min Tsai; Yu-Shu Liu; Wen-Chi Su; Yu-Chi Chou; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

2.  GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions.

Authors:  Sonia Brun; Eloïne Bestion; Eric Raymond; Firas Bassissi; Zuzana Macek Jilkova; Soraya Mezouar; Madani Rachid; Marie Novello; Jennifer Tracz; Ahmed Hamaï; Gilles Lalmanach; Lise Vanderlynden; Raphael Legouffe; Jonathan Stauber; Thomas Schubert; Maximilian G Plach; Jérôme Courcambeck; Cyrille Drouot; Guillaume Jacquemot; Cindy Serdjebi; Gael Roth; Jean-Pierre Baudoin; Christelle Ansaldi; Thomas Decaens; Philippe Halfon
Journal:  Autophagy       Date:  2021-11-05       Impact factor: 13.391

3.  MicroRNA-375 Targets ATG14 to Inhibit Autophagy and Sensitize Hepatocellular Carcinoma Cells to Sorafenib.

Authors:  Shuo Yang; Minggang Wang; Liang Yang; Yan Li; Yingbo Ma; Xueqiang Peng; Xinyu Li; Bowen Li; Hongyuan Jin; Hangyu Li
Journal:  Onco Targets Ther       Date:  2020-04-28       Impact factor: 4.147

Review 4.  Melatonin as an Antitumor Agent against Liver Cancer: An Updated Systematic Review.

Authors:  Paula Fernández-Palanca; Carolina Méndez-Blanco; Flavia Fondevila; María J Tuñón; Russel J Reiter; José L Mauriz; Javier González-Gallego
Journal:  Antioxidants (Basel)       Date:  2021-01-12

Review 5.  Autophagy in liver diseases.

Authors:  Elias Kouroumalis; Argryro Voumvouraki; Aikaterini Augoustaki; Dimitrios N Samonakis
Journal:  World J Hepatol       Date:  2021-01-27

6.  Autophagy activity in cholangiocarcinoma is associated with anatomical localization of the tumor.

Authors:  Gábor Lendvai; Tímea Szekerczés; Ildikó Illyés; Milán Csengeri; Krisztina Schlachter; Erzsébet Szabó; Gábor Lotz; András Kiss; Katalin Borka; Zsuzsa Schaff
Journal:  PLoS One       Date:  2021-06-15       Impact factor: 3.240

Review 7.  Inflammation in Primary and Metastatic Liver Tumorigenesis-Under the Influence of Alcohol and High-Fat Diets.

Authors:  Lauren S Strathearn; Afanasii I Stepanov; Joan Font-Burgada
Journal:  Nutrients       Date:  2020-03-27       Impact factor: 5.717

8.  Dysregulated FAM215A Stimulates LAMP2 Expression to Confer Drug-Resistant and Malignant in Human Liver Cancer.

Authors:  Po-Shuan Huang; Yang-Hsiang Lin; Hsiang-Cheng Chi; Yi-Hsin Tseng; Cheng Yi Chen; Tzu-Kang Lin; Chau-Ting Yeh; Kwang-Huei Lin
Journal:  Cells       Date:  2020-04-14       Impact factor: 6.600

9.  Yeast β-D-glucan exerts antitumour activity in liver cancer through impairing autophagy and lysosomal function, promoting reactive oxygen species production and apoptosis.

Authors:  Ningning Wang; Hongzhi Liu; Guijun Liu; Min Li; Xuxiao He; Chunzhao Yin; Qiaochu Tu; Xia Shen; Wenqiang Bai; Qiang Wang; Yongzhen Tao; Huiyong Yin
Journal:  Redox Biol       Date:  2020-03-07       Impact factor: 11.799

Review 10.  Involvement of Nucleotide-Binding Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome in the Pathogenesis of Liver Diseases.

Authors:  Congjian Shi; Hongqin Yang; Zhenghong Zhang
Journal:  Front Cell Dev Biol       Date:  2020-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.